740867 SE Klinisches Prüfpräparat (Investigational Medicinal Product, IMP) - Dossier (2 Gruppen)
Sommersemester 2025 | Stand: 09.12.2024 | LV auf Merkliste setzen740867
SE Klinisches Prüfpräparat (Investigational Medicinal Product, IMP) - Dossier (2 Gruppen)
SE 1
1
Block
jährlich
Englisch
• Students should understand the content and structure of an IMPD and its role in the development process
• They should be capable of placing information in the relevant sections
• Structure of the IMPD
• IMPD content reflecting the developmental stage
• From IMPD to Marketing Authorization Dossier Module 3
• Current requirements according to the CTR (CTIS)
• Practical example of writing an IMPD
seminar applying theoretic knowledge to specific practical situations
active participation in seminar demonstrating understanding of theoretical principles and critical reasoning
Modules 1 and 2
siehe Termine
|
Gruppe 0
|
||||
|---|---|---|---|---|
| Datum | Uhrzeit | Ort | ||
|
Mo 28.04.2025
|
13.45 - 16.00 | L.03.112 L.03.112 | Krämer/Reischl | |
|
Di 29.04.2025
|
13.45 - 16.00 | L.03.121 L.03.121 | Krämer/Reischl | |
|
Mi 30.04.2025
|
13.45 - 16.00 | L.03.121 L.03.121 | Krämer/Reischl | |
|
Mo 05.05.2025
|
13.45 - 16.00 | L.03.112 L.03.112 | Krämer/Reischl | |
|
Di 06.05.2025
|
13.45 - 16.00 | Seminarraum 5 (Innrain 52a) 01G010 Seminarraum 5 (Innrain 52a) 01G010 | Barrierefrei | Krämer/Reischl |
| Gruppe | Anmeldefrist | |
|---|---|---|
| 740867-0 | 01.02.2025 00:00 - 21.02.2025 23:59 | |
| Krämer I., Reischl I. | ||